Investigation Overview
Company
Security
NASDAQ: NVIV
Summary
April 13, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) was announced over potential breaches of fiduciary duties by certain officers and directors at Invivo Therapeutics Holdings.
The investigation by a law firm concerns whether certain Invivo Therapeutics Holdings officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Invivo Therapeutics Holdings Corp (reported that its Net Loss declined from 433.31 million in2 105 to $23.44 million in 2016.
Shares of Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) declined from $17.78 per share in June 2015 to as low as $3.30 per share on April 13, 2017.